• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

准确诊断脑卒中合并心房颤动患者的病因:脑利钠肽的作用。

Accurate etiology diagnosis in patients with stroke and atrial fibrillation: A role for brain natriuretic peptide.

机构信息

Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

出版信息

J Neurol Sci. 2019 May 15;400:153-157. doi: 10.1016/j.jns.2019.03.031. Epub 2019 Mar 29.

DOI:10.1016/j.jns.2019.03.031
PMID:30953905
Abstract

BACKGROUND

Atrial fibrillation (AF) is the leading cause of cardioembolic stroke (CES), and patients with stroke and AF are frequently assumed to have CES. However, strokes presumably due to atherosclerotic pathophysiologies in large or small vessels can also occur in patients with AF. The aims of the present study were to clarify the prevalence of and factors related to a non-cardioembolic etiology in acute stroke patients with AF.

METHODS

From March 2011 through May 2017, consecutive acute ischemic stroke patients with AF were retrospectively recruited. The concomitant presence of non-cardioembolic features (small vessel occlusion [SVO] or large artery atherosclerosis [LAA]) on imaging was evaluated. The frequency of and factors associated with co-existing SVO/LAA features were assessed.

RESULTS

A total of 560 consecutive patients with AF and acute stroke (237 women; median age 78 [IQR 71-85] years; NIHSS score 9 [3-20]) were enrolled. Of these, 42 (7.5%) had co-existing SVO/LAA features. Multivariable logistic regression analysis showed that the brain natriuretic peptide level (BNP, OR 0.78, p = .030 per 100 pg/mL increase) was independently and negatively associated with co-existing SVO/LAA features and receiver operating characteristic curve analysis revealed the practical cut-off BNP value was 130 pg/mL (sensitivity 54% and specificity 68%).

CONCLUSION

SVO/LAA features were found in 7.5% of acute stroke patients with AF. A relatively low BNP level on admission was independently associated with co-existing SVO/LAA features. Thorough examination for a more appropriate etiology may be particularly necessary in acute stroke patients with AF and a relatively low BNP level.

摘要

背景

心房颤动(AF)是心源性脑栓塞(CES)的主要原因,患有中风和 AF 的患者通常被认为患有 CES。然而,在 AF 患者中,也可能发生归因于大或小血管动脉粥样硬化病理生理学的中风。本研究的目的是阐明伴有 AF 的急性中风患者中非心源性病因的流行情况和相关因素。

方法

从 2011 年 3 月至 2017 年 5 月,连续回顾性招募伴有 AF 的急性缺血性中风患者。评估影像学上同时存在的非心源性特征(小血管闭塞[SVO]或大动脉粥样硬化[LAA])。评估同时存在 SVO/LAA 特征的频率和相关因素。

结果

共纳入 560 例伴有 AF 和急性中风的连续患者(237 例女性;中位年龄 78[IQR 71-85]岁;NIHSS 评分 9[3-20])。其中,42 例(7.5%)存在同时存在的 SVO/LAA 特征。多变量逻辑回归分析显示,脑钠肽水平(BNP,OR 0.78,p=0.030 每增加 100pg/mL)与同时存在 SVO/LAA 特征独立且呈负相关,受试者工作特征曲线分析显示实际 BNP 截断值为 130pg/mL(敏感性 54%,特异性 68%)。

结论

在伴有 AF 的急性中风患者中发现 SVO/LAA 特征占 7.5%。入院时相对较低的 BNP 水平与同时存在 SVO/LAA 特征独立相关。在伴有 AF 和相对较低 BNP 水平的急性中风患者中,可能特别需要进行彻底检查以确定更合适的病因。

相似文献

1
Accurate etiology diagnosis in patients with stroke and atrial fibrillation: A role for brain natriuretic peptide.准确诊断脑卒中合并心房颤动患者的病因:脑利钠肽的作用。
J Neurol Sci. 2019 May 15;400:153-157. doi: 10.1016/j.jns.2019.03.031. Epub 2019 Mar 29.
2
Brain natriuretic peptide levels as a predictor for new atrial fibrillation during hospitalization in patients with acute ischemic stroke.脑利钠肽水平可预测急性缺血性脑卒中住院患者新发心房颤动。
Am J Cardiol. 2012 May 1;109(9):1303-7. doi: 10.1016/j.amjcard.2011.12.022. Epub 2012 Feb 15.
3
Correlation between plasma brain natriuretic peptide levels and left atrial appendage flow velocity in patients with non-valvular atrial fibrillation and normal left ventricular systolic function.非瓣膜性心房颤动且左心室收缩功能正常患者血浆脑钠肽水平与左心耳血流速度的相关性
J Echocardiogr. 2018 Jun;16(2):72-80. doi: 10.1007/s12574-017-0362-4. Epub 2017 Dec 18.
4
The value of the use of plasma B-type natriuretic peptide among acute ischemic stroke patients in a Chinese emergency department.中国急诊科急性缺血性卒中患者使用血浆B型利钠肽的价值。
Clin Neurol Neurosurg. 2013 Sep;115(9):1671-6. doi: 10.1016/j.clineuro.2013.02.021. Epub 2013 Mar 19.
5
N-terminal probrain natriuretic peptide as a biomarker of cardioembolic stroke.N 端脑利钠肽前体作为心源性脑栓塞的生物标志物。
Int J Stroke. 2011 Oct;6(5):398-403. doi: 10.1111/j.1747-4949.2011.00606.x. Epub 2011 Jun 6.
6
Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
.脑钠肽是房颤卒中患者预后的有力预测指标。
Cerebrovasc Dis Extra. 2017;7(1):35-43. doi: 10.1159/000457808. Epub 2017 Mar 2.
7
Plasma brain natriuretic peptide predicts death during hospitalization in acute ischaemic stroke and transient ischaemic attack patients with atrial fibrillation.血浆脑利钠肽可预测伴有心房颤动的急性缺血性卒中和短暂性脑缺血发作患者住院期间的死亡。
Eur J Neurol. 2011 Jan;18(1):165-9. doi: 10.1111/j.1468-1331.2010.03101.x.
8
Factors associated with proximal carotid axis occlusion in patients with acute stroke and atrial fibrillation.与急性脑卒中合并心房颤动患者近段颈动脉轴闭塞相关的因素。
J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):799-804. doi: 10.1016/j.jstrokecerebrovasdis.2013.07.002. Epub 2013 Oct 6.
9
Impact of Atrial Natriuretic Peptide Value for Predicting Paroxysmal Atrial Fibrillation in Ischemic Stroke Patients.心房利钠肽值对预测缺血性中风患者阵发性心房颤动的影响。
J Stroke Cerebrovasc Dis. 2017 Apr;26(4):772-778. doi: 10.1016/j.jstrokecerebrovasdis.2016.10.016. Epub 2016 Nov 18.
10
Brain natriuretic peptide as a predictor of delayed atrial fibrillation after ischaemic stroke and transient ischaemic attack.脑利钠肽作为缺血性卒中和短暂性脑缺血发作后心房颤动延迟的预测因子。
Eur J Neurol. 2010 Feb;17(2):326-31. doi: 10.1111/j.1468-1331.2009.02813.x. Epub 2009 Oct 21.

引用本文的文献

1
Clinical features of ischemic stroke in patients with nonvalvular atrial fibrillation combined with intracranial atherosclerotic stenosis.非瓣膜性心房颤动合并颅内动脉粥样硬化性狭窄患者缺血性脑卒中的临床特征。
Brain Behav. 2023 Jun;13(6):e3036. doi: 10.1002/brb3.3036. Epub 2023 May 1.
2
Effects of Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: A Secondary Analysis of the Randomized LOOP Study.基于氨基末端 B 型利钠肽原的心房颤动筛查效果:随机 LOOP 研究的二次分析。
Circulation. 2023 Jun 13;147(24):1788-1797. doi: 10.1161/CIRCULATIONAHA.123.064361. Epub 2023 Apr 15.
3
Predictive value of serum initial brain natriuretic peptide and troponin on functional prognosis in noncardiogenic patients with anterior and posterior circulation cerebral infarction.
血清初始脑利钠肽和肌钙蛋白对前后循环脑梗死非心源性患者功能预后的预测价值。
Arq Neuropsiquiatr. 2022 Oct;80(10):985-993. doi: 10.1055/s-0042-1755270. Epub 2022 Dec 19.
4
A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation.非瓣膜性心房颤动患者缺血性卒中评估生物标志物综述
Front Cardiovasc Med. 2021 Jul 1;8:682538. doi: 10.3389/fcvm.2021.682538. eCollection 2021.
5
B-type natriuretic peptide is associated with post-discharge stroke in hospitalized patients with heart failure.B 型利钠肽与心力衰竭住院患者出院后中风有关。
ESC Heart Fail. 2020 Oct;7(5):2508-2515. doi: 10.1002/ehf2.12818. Epub 2020 Jun 19.